SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-005721
Filing Date
2019-10-04
Accepted
2019-10-04 14:07:59
Documents
7
Period of Report
2019-09-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 21051
2 PLAN OF CONVERSION curr_ex21.htm EX-2.1 19328
3 CERTIFICATE OF CONVERSION curr_ex31.htm EX-3.1 3646
4 AMENDED AND RESTATED CERTIFICATE curr_ex32.htm EX-3.2 21316
5 DELAWARE BYLAWS curr_ex33.htm EX-3.3 108521
6 ARTICLES OF CONVERSION curr_ex34.htm EX-3.4 20341
7 curr_ex34img11.jpg GRAPHIC 183706
  Complete submission text file 0001477932-19-005721.txt   448607
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 191138357
SIC: 2673 Plastics, Foil & Coated Paper Bags